[Effect and tolerance of Biarison (proquazone) in rheumatoid arthritis (author's transl)].

  • 30 June 1978
    • journal article
    • abstracts
    • Vol. 120  (26) , 901-4
Abstract
Biarison was tested in 24 patients mainly with classical rheumatoid arthritis for its efficacy and tolerance. There was a distinct improvement in the course of the 4 weeks' therapy with a mean dosage of 900 mg/day (it was in the meantime raised to a maximum of 1500 mg/day in isolated cases) especially in the pain, stiffness and functional capacity. Biarison caused few gastrointestinal side effects: the tolerance may be said to be good on the whole.

This publication has 0 references indexed in Scilit: